These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37967350)
1. Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report. Phaterpekar T; Nunez JJ; Morton E; Liu YS; Cao B; Frey BN; Milev RV; Müller DJ; Rotzinger S; Soares CN; Taylor VH; Uher R; Kennedy SH; Lam RW J Clin Psychiatry; 2023 Nov; 85(1):. PubMed ID: 37967350 [No Abstract] [Full Text] [Related]
2. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1. Nunez JJ; Nguyen TT; Zhou Y; Cao B; Ng RT; Chen J; Frey BN; Milev R; Müller DJ; Rotzinger S; Soares CN; Uher R; Kennedy SH; Lam RW PLoS One; 2021; 16(6):e0253023. PubMed ID: 34181661 [TBL] [Abstract][Full Text] [Related]
3. Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. Morton E; Bhat V; Giacobbe P; Lou W; Michalak EE; McInerney S; Chakrabarty T; Frey BN; Milev RV; Müller DJ; Parikh SV; Rotzinger S; Kennedy SH; Lam RW; CNS Drugs; 2021 Apr; 35(4):439-450. PubMed ID: 33860922 [TBL] [Abstract][Full Text] [Related]
4. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study. Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231 [TBL] [Abstract][Full Text] [Related]
5. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD. Cohen RM; Greenberg JM; IsHak WW JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512 [TBL] [Abstract][Full Text] [Related]
6. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH; BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692 [TBL] [Abstract][Full Text] [Related]
7. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. Demyttenaere K; Andersen HF; Reines EH Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937 [TBL] [Abstract][Full Text] [Related]
8. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study. Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399 [TBL] [Abstract][Full Text] [Related]
10. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D. Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937 [TBL] [Abstract][Full Text] [Related]
11. Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach. Salem H; Huynh T; Topolski N; Mwangi B; Trivedi MH; Soares JC; Rush AJ; Selvaraj S J Affect Disord; 2023 Mar; 324():286-293. PubMed ID: 36584711 [TBL] [Abstract][Full Text] [Related]
12. Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study. Steiner AJ; Boulos N; Wright SM; Mirocha J; Smith K; López E; Gohar SH; Ishak WW J Psychiatr Pract; 2017 Sep; 23(5):328-341. PubMed ID: 28961662 [TBL] [Abstract][Full Text] [Related]
13. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416 [TBL] [Abstract][Full Text] [Related]
15. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up. IsHak WW; Mirocha J; James D; Tobia G; Vilhauer J; Fakhry H; Pi S; Hanson E; Nashawati R; Peselow ED; Cohen RM Acta Psychiatr Scand; 2015 Jan; 131(1):51-60. PubMed ID: 24954156 [TBL] [Abstract][Full Text] [Related]
16. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report. Kennedy SH; Lam RW; Rotzinger S; Milev RV; Blier P; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Giacobbe P; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; McInerney S; MacQueen GM; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Sassi RB; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Yu J; Uher R; J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30840787 [TBL] [Abstract][Full Text] [Related]
17. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity. IsHak WW; Steiner AJ; Klimowicz A; Kauzor K; Dang J; Vanle B; Elzahaby C; Reid M; Sumner L; Danovitch I Psychopharmacol Bull; 2018 Jan; 48(1):8-25. PubMed ID: 29382957 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials. Jha MK; South C; Trivedi J; Minhajuddin A; Rush AJ; Trivedi MH Int J Neuropsychopharmacol; 2019 May; 22(5):339-348. PubMed ID: 30958879 [TBL] [Abstract][Full Text] [Related]
19. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach. Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180 [TBL] [Abstract][Full Text] [Related]
20. Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment. López E; Steiner AJ; Manier K; Shapiro BB; Vanle B; Parisi T; Dang J; Chang T; Ganjian S; Mirocha J; Danovitch I; IsHak WW J Affect Disord; 2018 Jan; 225():117-122. PubMed ID: 28826087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]